| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 28.158 | 23.234 | 705 | 21.710 | 50.361 | 60.467 | 154.848 | 136.060 |
| Total Income - EUR | - | - | 28.158 | 23.234 | 705 | 21.710 | 50.361 | 60.467 | 154.848 | 136.060 |
| Total Expenses - EUR | - | - | 7.742 | 9.955 | 1.716 | 7.430 | 8.990 | 9.697 | 55.574 | 31.432 |
| Gross Profit/Loss - EUR | - | - | 20.417 | 13.279 | -1.010 | 14.280 | 41.371 | 50.770 | 99.273 | 104.627 |
| Net Profit/Loss - EUR | - | - | 19.572 | 13.047 | -1.017 | 14.075 | 40.878 | 50.179 | 97.825 | 100.627 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
Check the financial reports for the company - Eye & Skin Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.327 | 2.306 | 1.187 | 571 | 95 | 0 | 0 | 24.545 |
| Current Assets | - | - | 19.101 | 11.094 | 6.182 | 22.947 | 41.218 | 51.259 | 100.110 | 95.168 |
| Inventories | - | - | 0 | 0 | 0 | 112 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 3.222 | 4.244 | 1.765 | 3.318 | 3.375 | 42.923 | 79.333 | 80.193 |
| Cash | - | - | 15.879 | 6.851 | 4.417 | 19.517 | 37.843 | 8.336 | 20.777 | 14.974 |
| Shareholders Funds | - | - | 19.616 | 13.099 | 7.381 | 21.317 | 39.965 | 50.291 | 97.937 | 100.746 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 812 | 302 | 0 | 2.222 | 1.363 | 983 | 2.308 | 18.967 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Eye & Skin Medical Srl